Back to search
FDAFDA · Food and drugs·Recall number D-1141-2015

NEXIUM® (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.

Published June 24, 2015 · Recall initiated: June 10, 2015

Summary

FDA records drug Class II recall D-1141-2015, published June 24, 2015 and initiated June 10, 2015. Recalling firm: AstraZeneca Pharmaceuticals LP; Status: Terminated; Reported quantity: 34,524 bottles; Lot: Lot # FC0064; Exp. 05/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM® capsules contained 60 SEROQUEL® XR tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AstraZeneca Pharmaceuticals LP
Distributor
Nationwide to wholesalers for further distribution at the retail level.
Lot
Lot # FC0064; Exp. 05/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was NEXIUM® (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31. recalled?

Yes. FDA published recall D-1141-2015 on June 24, 2015. Reported hazard: Presence of Foreign Tablets/Capsules: Confimed customer compliant by a retail pharmacist that an unopened bottle labeled as NEXIUM® capsules contained 60 SEROQUEL® XR tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter